Patients with familial hypocalciuric hypercalcemia type-3, a disorder due to mutations of the adaptor protein-2 (AP2) leading to defective clathrin-mediated endocytosis, have an increased expression of CaSR at the plasma membrane78. The gene discussed is TFAP2A; the disease is Familial hypocalciuric hypercalcemia type 3.